Government News  
Government News and Press Releases Bookmark Us
 Home > European Union News and Press Releases > 2006 > April Saturday 22 November 2008
28th April, 2006

Adoption of a Regulation on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems

[Graphic in PDF & Word format] COUNCIL OF THE EUROPEAN UNION EN C/06/120 Brussels, 28 April 2006 8745/06 (Presse 120) Adoption of a Regulation on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems

The Council adopted[1] today in first reading a Regulation on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems. (PE-CONS 3674/05)

This Regulation aims at facilitating and regulating at Community level the granting of compulsory licences for the supply of patented pharmaceutical products to countries in need. After its entry into force, it will allow to handle cases of public health emergencies, such as the avian flu, in poor developing countries lacking the capacity to manufacture such medicines locally.

Intensive cooperation between the Council and the European Parliament has allowed the rapid adoption of this Regulation which is directly applicable in all Member States since the date of its entry into force i.e. on the twentieth day following its publication in the Official Journal of the EU.

The two co legislators agreed to modify the Commission's proposal in particular by widening the list of countries eligible to benefit from the import of products licensed under the Regulation to include not only members of the WTO but also other least-developed and developing countries.

The text of the Regulation makes clear that the compulsory licensing system set up by this Regulation is intended to address public health problems and therefore it should not be used by countries to pursue industrial or commercial policy objectives. Moreover it specifies that products manufactured pursuant to this Regulation reach only those who need them and are not diverted from those for whom they were intended.

The issuing of compulsory licences under this Regulation imposes clear conditions upon the licensee as regards the acts covered by the licence, the identification of the pharmaceutical products manufactured under the licence and the countries to which the products will be exported.

[1] The German delegation abstained.

 
Read All European Union Press Releases
More European Union Press Releases
Telecoms Rules: Commission refers Poland and Belgium to the European Court of Justice
Preparation Agriculture/Fisheries Council of April 2006
Commissioner Piebalgs and Russian Energy Minister Khristenko meet in the first bilateral Conference on energy strategies
Green Paper on improving the efficiency of the enforceability of cross-boarder debt collection
Top News from the European Commission 2 May – 21 May 2006
Search
Search is currently disabled.

Privacy Policy | Disclaimer | Resources
Government News © 2008